ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

The Be Active trial demonstrates the efficacy of scalable interventions, incorporating remote monitoring and behavioral economics, in boosting physical activity among high-risk cardiovascular patients. Lasting effects were observed even six months post-intervention. While additional data may be warranted for some stakeholders, these interventions hold promise as integral components of exercise-based prevention strategies for cardiovascular disease.  In this interview, Alexander Fanaroff, MD, MHS and Glenn A. Hirsch MD, MHS, FACC discuss results from the Be Active RCT.    Subscribe on Apple Podcasts |  

The podcast discusses the VICTORION-INITIATE study showing superior outcomes with inclisarin for lipid-lowering therapy. Topics include challenges in achieving optimal lipid levels, efficacy of inclisarin versus usual care, and optimizing lipid control with pharmacists.

Cardiologists James Januzzi and Alison Bailey discuss ARISE-HF study results on diabetic cardiomyopathy. They explore the effects of aldose reductase inhibitors in preventing cardiomyopathy in diabetic patients, criteria for participant selection in heart failure trials, selective testing for high-risk subgroups, and the impact of AT-001 on delaying heart failure symptoms.

Cardiologist Jerry Blackwell discusses the future of cardiology, emphasizing value-based care and reducing costs while enhancing patient care. The podcast explores the impact of middlemen on healthcare costs, the evolution of cardiology practice landscape, and the role of private equity. Furthermore, it delves into emerging trends and concerns in cardiology training and professionalism.

Cardiologists Javed Butler and Sun Moon Kim discuss EMPACT-MI trial results on heart failure risk post-myocardial infarction. They explore misconceptions on EF percentages, diuretics, and benefits of SGLT2 inhibitors. Real-world evidence shapes future treatment strategies.

Experts discuss the challenges and advancements in managing heart failure with preserved ejection fraction, including the effectiveness of SGLT2 inhibitors, mineralocorticoid receptor antagonists, and other targeted therapies. They also explore the evolving landscape of device therapy for this population, offering practical guidance for clinicians.

Aortic valve disease is often identified too late before clinicans can provide meaningful prevention.  Identifying aortic valve calcium opens the door for potential prevention of progression: a phenotype researchers could build randomized controlled trials around.     In this interview, Richard A. Chazal MD, MACC and Michael J. Blaha, MD, MPH discuss Prevalence of Aortic Valve Calcium and the Long-Term Risk of Incident Severe Aortic Stenosis.     Subscribe on Apple Podcasts | Subscribe to ACCEL 

Experts discuss the importance of monitoring LDL cholesterol levels after a heart attack to prevent future incidents. Topics include the evolution of LDL measurements, lipid level management, and the role of fasting in testing. They also analyze the testing rates among Medicare beneficiaries and the impact of LDL measurements on treatment adherence and care interventions.

This episode covers a review on disparities in cardiovascular perioperative health care. The writers propose actionable solutions utilizing multidisciplinary perspectives from cardiology, cardiac surgery, cardiothoracic anesthesiology, critical care, medical ethics, and health disparity experts.  In this interview, Adam J. Milam, MD, PhD, and Clyde W.Yancy, MD, MSc, MACC, discuss the JACC State-of-the-Art Review: Racial and Ethnic Disparities in Perioperative Health Care Among Patients Undergoing Cardiac Surgery.   Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL 

Cardiac imaging is increasingly used in the workup of coronary artery disease, with growth greatest for CCTA and with falling use of SPECT. Because of the low cost of computed tomography, this growing use of imaging has had only a small impact on cost of provision of diagnostic imaging in this population.  In this interview, Jonathan R. Weir-McCall, PhD, and Christopher M. Kramer, MD, FACC, discuss From JACC: National Trends in Coronary Artery Disease Imaging: Associations With Health Care Outcomes and Costs.    Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL